Relation raises $35M, with Nvidia and Deerfield backing, for computational drug discovery

The venture arm of Nvidia, the supercomputing giant rising up the world’s most valuable companies chart, is backing a computational drug discovery startup that’s headed toward the clinic for osteoporosis, a large field with few innovations.

Relation Therapeutics has added $35 million to its coffers, the company exclusively told Endpoints News. Nvidia’s NVentures, DCVC, Deerfield Management Company, Khosla Ventures, Abcam founder Jonathan Milner, ARK Invest and Magnetic Ventures contributed funds, which bring the total seed financing to $60 million.

The London-based upstart brings together machine learning, genomics and other tools in an integrated wet and dry lab. It has built what it deems the largest single-cell bone atlas, which is derived from human tissue.

“If you look at technological deployments in general, they tend to get over-deployed into problem spaces where they’re really not needed, so one of the big questions in Relation is…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks